Form 4: Pharvaris Executive Sells Shares
Statement of Changes in Beneficial Ownership
Anna Nijdam, Principal Accounting Officer at Pharvaris N.V., reported a sale of 2,670 common shares on June 4, 2026.
Summary
- Anna Nijdam, Principal Accounting Officer of Pharvaris N.V., sold 2,670 shares of common stock on June 4, 2026.
- The sale was executed at a weighted average price of $30.87 per share, with individual transactions ranging from $30.68 to $31.30.
- These shares were acquired upon the vesting of restricted stock units on various dates.
- Following the transaction, Ms. Nijdam beneficially owns 46,275 shares of common stock directly.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the sale of shares by a key executive, although the context of vested RSUs and the offer to provide detailed pricing information mitigates extreme concern.
Negatives
- A significant number of shares were sold by a key executive, which could be interpreted negatively by the market.
Future Outlook
No forward-looking statements or guidance are present in this filing.
Management Comments
- The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While sales by executives can sometimes signal a lack of confidence, they can also be part of pre-planned diversification or liquidity strategies, especially when related to vested equity awards.
Stakeholder Impact
- Shareholders may view the sale of shares by an executive with some concern, potentially impacting short-term stock sentiment.
- The company's management team continues to hold a significant number of shares, indicating ongoing commitment.
Key Dates
| Date | Description |
|---|---|
| 06/04/2026 | Transaction Date (Sale of common stock) |
| 06/08/2026 | Date of signature on the filing |
Keywords
Pharvaris N.V., PHVS, Form 4, Insider Trading, Stock Sale, Beneficial Ownership, Restricted Stock Units, Anna Nijdam
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.